What Otus does

Otus (오투스) is a South Korean health technology brand operated by Edenlux Co., Ltd. (주식회사 에덴룩스), specializing in consumer eye health devices. Founded in 2014 by Park Seong-yong (박성용), a former medical professional who pivoted to eye health R&D after personal vision impairment, the company is headquartered in Seoul with operations and CS functions in Changwon. Its flagship product is the Otus Plus AI Eye Exerciser (오투스플러스 AI 눈 운동기), an automated device with motor-driven lens movement designed to exercise eye muscles for relief of eye fatigue, myopia management, presbyopia training, and general vision maintenance. The company sells primarily through direct-to-consumer e-commerce at otuseye.com, with international shipping configured to over 100 countries and multilingual support (Korean, English, Japanese). A small accessory ecosystem — vision correction clips (KRW 5,500) and replacement face pads (KRW 6,600) — generates consumable/recurring revenue tied to the installed base of main devices, which are priced at KRW 398,000 (list price KRW 830,000).

The business model is DTC e-commerce with no disclosed retail or enterprise channels. The company has raised approximately $4.4M in cumulative disclosed funding across multiple rounds (2016–2022) from Korean institutional investors including Korea Investment Partners, HB Investment, KDB Bank Europe, A STONE VENTURES, TimeWorks Investments, and G.N. Tech Venture, plus government-linked vehicles (Korea Science and Technology Holdings, TIPS Program). Engagement signals include 1,327+ customer reviews on the flagship product and 106 pages of Q&A (520+ questions), suggesting an active community of consumer buyers. In January 2026, the company announced a partnership with the McKinney Economic Development Corp. (MEDC) Innovation Fund to establish operations in McKinney, Texas, marking its first formal U.S. market entry.

The core product technology is described as "AI-powered" with automatic lens control for eye muscle training, but no patents, proprietary ML models, research publications, or third-party clinical validation are disclosed in available data. The "AI" positioning appears to primarily reflect automated/programmed motor control rather than data-driven machine learning. No regulatory clearances (FDA, CE Mark, MFDS), certifications, or clinical efficacy studies are documented in the input, which is notable for a device making medical-adjacent claims (myopia management, presbyopia improvement). Customer base is exclusively individual consumers with no enterprise or institutional contracts disclosed, and headcount remains small (11–50 employees).

Name

Otus

Legal name

주식회사 에덴룩스 (Edenlux Co., Ltd.)

Website

https://otuseye.com

Company type

Private

Founded year

2014

Operating status

Operating

Headcount range

11–50 employees

Short description

Otus (Edenlux Co., Ltd.) is a South Korean DTC brand selling an automated eye exercise device and accessories directly to individual consumers through its e-commerce platform, shipping to 100+ countries. Founded 2014 by a former medical professional, it targets eye fatigue, myopia, and presbyopia relief.

Ownership category

akta.pro rank

Product category

Eye Health Devices

NAICS

Optical Goods Retailers (45613), Ophthalmic Goods Manufacturing (339115)

SIC

Ophthalmic Goods (3851)

akta.pro primary industry

Eye, Ear & Nasal Care (HLAIADAF)

akta.pro secondary industry

Edge AI Deployment, Orchestration & OTA Model Updates (HDAAAJAI)

Keywords

• Eye exercise devices
• AI vision training
• Eye health products
• Myopia management devices
• Presbyopia eye training

Headquarters

HQ city

Seongsan

HQ country

South Korea

HQ region

Asia

Offices2 records

Markets served

GTM type

B2C

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Supply Chain, Operations, Marketing or Sales, Personnel

Revenue model

1. Product Sales: Direct-to-consumer e-commerce sales of eye health devices and accessories through otuseye.com. Products include main devices (AI eye exerciser) and consumables/accessories (face pads, degree clips).
2. Subscription/Recurring: Regular delivery subscription option available for product purchases, offering convenience for consumable products like face pads.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels4 records

Core offering

Otus (operated by Edenlux Co., Ltd.) designs, manufactures, and sells an AI-powered eye exercise device (Otus Plus AI Eye Exerciser / 오투스플러스 AI 눈 운동기) that uses automated lens movement to train eye muscles. The product is sold alongside consumable accessories including vision correction clips and replacement face pads, primarily through the company's own e-commerce store at otuseye.com.

Product overview

Otus (에덴룩스) is a South Korean health technology brand specializing in eye health solutions. The company offers a portfolio of eye exercise devices and accessories centered around its flagship AI-powered eye exercise device (오투스플러스 AI 눈 운동기), complemented by accessories such as vision correction clips and replacement face pads. The brand operates under Edenlux Co., Ltd. (주식회사 에덴룩스) and sells primarily through its e-commerce platform otuseye.com, with international shipping available to multiple countries.

Differentiator

Problem solved

Functional benefit

Products and services

• Otus Plus AI Eye Exercise Device (오투스플러스 AI 눈 운동기) AI-powered eye exercise device that uses automated lens movement to train eye muscles; targets eye fatigue, myopia, presbyopia, and overall vision improvement for individual consumers.
• Otus Vision Correction Clip (오투스 도수클립) Vision correction clip accessory designed to be attached to the Otus Plus AI Eye Exercise Device, sold as a standalone add-on.
• Otus Face Pad (오투스 안면패드) Replacement face pad consumable for the Otus Plus AI Eye Exercise Device, available with subscription/recurring delivery for convenience.

Named customers1 record

Segments1 record

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Partnerships

One partnership is on record.

• McKinney Economic Development Corp. (MEDC)strategicStrategic or Co-development Partner · 13 January 2026The MEDC's Innovation Fund is bringing South Korea-based Edenlux to McKinney, Texas. This marks Edenlux's entry into the U.S. market through this economic development initiative. Michael Kowski, president and CEO of MEDC, and Sungyong Park, founder and CEO of Edenlux, participated in the announcement.

Scale indicators5 records

Recent moves6 records

Expansion highlights4 records

Direct peers

• Warby Parker: Warby Parker is a direct-to-consumer eyewear and vision-care brand selling prescription glasses, contacts, and eye exams online. It is comparable to Otus in DTC channel model and consumer target (vision-concerned individuals), though focused on eyewear rather than devices.
• Hubble Contacts: Hubble Contacts is a DTC contact lens subscription brand selling affordable vision correction online. It shares Otus's DTC e-commerce approach and consumer vision-care positioning, though operating in contacts rather than eye exercise devices.
• EyeQue: EyeQue sells direct-to-consumer vision-measurement and eye-training devices (e.g., VisionCheck, Eye Exerciser) for at-home use. It is the closest direct peer to Otus in terms of DTC consumer eye-health hardware targeting myopia, presbyopia, and vision improvement without requiring a clinic visit.

Broad incumbents

• EssilorLuxottica: EssilorLuxottica is the world's largest eyewear and lens manufacturer with brands including Ray-Ban, Oakley, and LensCrafters. It is a broad incumbent in vision correction and could plausibly enter the eye-training device category.
• Bausch + Lomb: Bausch + Lomb is a global ophthalmic products company covering prescription lenses, OTC eye drops, and vision supplements. It competes in adjacent eye-care consumer categories where Otus positions its device for fatigue, myopia, and presbyopia.
• Johnson & Johnson Vision: Johnson & Johnson Vision is a major global vision-care incumbent offering contact lenses, surgical equipment, and consumer eye-health products. It is a broad incumbent in the same eye-care space where Otus operates, with vastly greater clinical evidence and distribution.

Emerging players

• NovaBay Pharmaceuticals: NovaBay is a US-based pharmaceutical company focused on eye and skin health products, including prescription and OTC eye care. It is comparable as a smaller player in the eye-care consumer health space where Otus also competes for share-of-wallet.

Regional players

• Plusoptix: Plusoptix is a German medical-device company specializing in pediatric vision screening devices (autorefractors). It is comparable in producing hardware-based eye diagnostic/screening devices for clinical and consumer-adjacent channels, though focused on pediatric screening rather than adult eye exercise.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds6 records

Investors9 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Otus